Newsroom
Call for Submissions - Advances in Rheumatic Disease Treatments
Rheumatic and musculoskeletal diseases such as rheumatoid arthritis, lupus, and osteoarthritis affect millions of patients worldwide. While often chronic and debilitating, recent years have brought exciting advances in pharmacological treatments and non-pharmacological therapies. Cureus requests original research articles, review articles, technical reports, and case reports that explore novel therapeutic approaches and agents for rheumatic disease management. We aim to provide clinicians with cutting-edge insights into optimized care for this complex patient population. Please include the keyword "Rheumatic Diseases" in your submission. Example topics include: Impact of SARS-CoV-2/COVID-19 on Provision of Medical Care to Patients With Systemic Autoimmune Rheumatic Disease and the Practice of Rheumatology Pathophysiology, Diagnosis, and Management of Takayasu Arteritis: A Review of Current Advances Oral Microbiome in Pre-Rheumatoid Arthritis: The Role of Aggregatibacter Actinomycetemcomitans in Bacterial Composition Dairy Consumption: Does It Make an Impact on Self-Reported Disease Activity of Inflammatory Arthritis? Submission Deadline: October 31, 2023 Published articles will be promoted through our social media channels, a dedicated email campaign, and article roundups, ensuring maximum impact and exposure to a wide audience of medical professionals. Don’t miss this opportunity to share your work on the future of rheumatology.
Sep 05, 2023
Rheumatoid Arthritis Associated with Increased Risk of Heart Attack, Stroke, Finds Meta-Analysis
An article published in Cureus was recently mentioned by Managed Healthcare Executive in an article about the association between rheumatoid arthritis and the rick of heart attack and stroke. "A new meta-analysis confirms that rheumatoid arthritis (RA) is a significant risk factor for cardiovascular disease, and for myocardial infarction and stroke, in particular. The report, which was published in the journal Cureus, is believed to be the first to incorporate recent new studies on RA and CVD incidence." Read the full article from Managed Healthcare Executive here.
Jul 27, 2023
Cureus Impact Factor Announcement
We're excited to share a significant milestone with you all. The annual release of Clarivate’s Journal Citation Report (JCR) revealed that The Cureus Journal of Medical Science has been awarded its first Impact Factor (IF). This is a noteworthy achievement for our community, and we are proud to share it with you. Both the 2022 two-year IF and five-year IF are 1.2. These Impact Factors place us in the mid-ranking for medicine, a commendable achievement for a journal that prides itself on inclusivity and accessibility. Impact Factors, alongside other metrics such as turnaround time, downloads and social media mentions can help to provide an overall assessment of journal quality and its research output in the community. Cureus metrics: Average Submission to Publication Time: 33 Days Total 2022 Article Views: 40.5 Million Articles Published for Free: 31% While we celebrate this achievement, we wish to restate that Cureus is a DORA signatory and reaffirm our commitment to assessing individual research articles on their own merits, rather than on an aggregate citation count for the journal. This is why we provide article-level metrics on every article page. We understand the importance of Impact Factor to many in the academic community, and as an academic publisher closely attuned to the needs of the research community, we acknowledge its significance. We believe that our inclusion in the Web of Science, and the subsequent Impact Factors, will be beneficial for many academics whose research output is still measured by metrics such as IF. We hope that, alongside this information, our article-level metrics and transparent publishing process will encourage more physicians and medical researchers to submit their work to Cureus, and thus benefit from broad readership and high-quality peer review. Your contributions, whether as authors, reviewers, or readers, have played a crucial role in this accomplishment. We encourage you to continue with us on our journey to democratize medical publishing. - The Cureus Team
Jun 30, 2023
Call for Submissions: Healthcare Systems Around the World
Screwed-up medical systems are a global problem, but successful healthcare models also exist in surprising locations. Quality, cost, equity, innovation, regulation, and more - where does your country fall short in its healthcare systems, and where does it excel? This call for submissions aims to foster a global dialogue among physicians and public health researchers deep in the medical trenches on important issues that inevitably impact patient care and outcomes. We encourage authors to reflect on personal experiences as healthcare providers, policymakers, or even medically knowledgeable patients. By sharing these perspectives, we can envision better healthcare systems for all. Eligible submissions from authors of all backgrounds, including healthcare professionals, researchers, and policymakers, will undergo editorial and peer review prior to publication. Due to the high quality of submissions we have received so far, we have decided to continue this “Healthcare Systems Around the World” call for submissions indefinitely. Requirements: Eligible submissions must include an author with publishing experience who has completed residency training. Submissions must include the keyword “Global Healthcare Systems”. Submissions must adhere to Cureus publishing guidelines and, if applicable, may be subject to Preferred Editing fees. Example editorials: Challenges faced by Pakistani healthcare system: Clinician's perspective Lebanese Healthcare System: How Will the Aftermath Look? COVID-19 Pandemic and Challenges for Socio-Economic Issues, Healthcare and National Health Programs in India The Healthcare Model: Concepts and Challenges for Primary Healthcare in Brazil An Assessment of Canada’s Healthcare System Weighing Achievements and Challenges
Jun 01, 2023
Psychoactive Drug Treatment Submissions
We’d like to thank all of the authors who participated in our “Therapeutic Psychoactive Drug Treatments” call for submissions. Once thought to be a dangerous and taboo part of counterculture, psychoactive drugs are gaining mainstream acceptance in the medical community. Several states and cities in the United States and countries around the world are beginning to legalize or decriminalize psilocybin and other psychoactive drugs for therapeutic or medicinal purposes. (1) Click below to view the articles published on this topic, and stay on the lookout for new calls for article submissions on major clinical topics.
May 19, 2023
Score and Comment on Articles from our ChatGPT Contest
We recently hosted a call for submissions contest for case reports, but our authors didn’t submit alone. They had help from ChatGPT, the cutting-edge language model trained to assist with natural language processing. With ChatGPT's assistance, authors have submitted detailed case reports. Now, we're curious - do you think there's a place for ChatGPT in medical publishing? Does this technology have the potential to revolutionize the way we approach medical research and publishing or could this lead us down a dangerous path? We invite you to read the published articles (more are on the way) and see for yourself. We would love to hear your thoughts on this exciting topic, so please read, rate (using our SIQ scoring system), and comment on the case reports. We appreciate your feedback and look forward to discussing the future of medical publishing with you.
May 19, 2023
The Wall of Shame and Recentering the Focus on the Academic Record
Let’s talk about the Wall of Shame. As a peer-reviewed medical journal, we have a fundamental responsibility to ensure that potentially dangerous medical misinformation is not published. With traditional research integrity methods sometimes falling short, we decided to conduct an experiment by highlighting authors who have committed egregious ethical violations as well as the institutions that enabled them. While we will never abandon this responsibility, we have decided to remove the Wall of Shame tomorrow, May 12th, 2023. Why, you may be asking? Especially when the Cureus community of authors, readers and reviewers were overwhelmingly supportive? We recognize that this is an ongoing problem, but we have determined that there are better ways of addressing academic fraud and dishonesty than by publicly sharing lists of authors. We wish to recenter the focus on correcting the academic record, as that is the ultimate goal of any correction or retraction. We will continue to vigorously investigate allegations of academic fraud and dishonesty, and we will do so objectively, without levying judgment on authors deemed to have acted unethically.
May 11, 2023
